WO2012020991A3 - Composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs - Google Patents

Composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs Download PDF

Info

Publication number
WO2012020991A3
WO2012020991A3 PCT/KR2011/005853 KR2011005853W WO2012020991A3 WO 2012020991 A3 WO2012020991 A3 WO 2012020991A3 KR 2011005853 W KR2011005853 W KR 2011005853W WO 2012020991 A3 WO2012020991 A3 WO 2012020991A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
tyrosine
preventing
amino acid
active ingredients
Prior art date
Application number
PCT/KR2011/005853
Other languages
English (en)
Korean (ko)
Other versions
WO2012020991A2 (fr
Inventor
임우택
김윤배
이정용
연성호
이진채
구교철
Original Assignee
월드웨이㈜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 월드웨이㈜ filed Critical 월드웨이㈜
Priority to CN2011800493075A priority Critical patent/CN103209697A/zh
Publication of WO2012020991A2 publication Critical patent/WO2012020991A2/fr
Publication of WO2012020991A3 publication Critical patent/WO2012020991A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs et concerne un procédé de production de celle-ci. La composition de la présente invention est exceptionnellement efficace dans la maladie de Parkinson, l'infarctus cérébral, l'accident vasculaire cérébral ou la démence.
PCT/KR2011/005853 2010-08-11 2011-08-10 Composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs WO2012020991A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011800493075A CN103209697A (zh) 2010-08-11 2011-08-10 包含丝氨基酸和酪氨酸的用于预防及改善脑疾病的组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0077583 2010-08-11
KR1020100077583A KR101048657B1 (ko) 2010-08-11 2010-08-11 실크 아미노산 및 티로신을 유효성분으로 포함하는 뇌질환 예방 및 개선용 조성물

Publications (2)

Publication Number Publication Date
WO2012020991A2 WO2012020991A2 (fr) 2012-02-16
WO2012020991A3 true WO2012020991A3 (fr) 2012-05-24

Family

ID=44923501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005853 WO2012020991A2 (fr) 2010-08-11 2011-08-10 Composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs

Country Status (3)

Country Link
KR (1) KR101048657B1 (fr)
CN (1) CN103209697A (fr)
WO (1) WO2012020991A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6667194B2 (ja) * 2014-04-28 2020-03-18 不二製油株式会社 脳神経疾患の予防又は脳機能改善用食品を製造するための食品添加物
CN104606178A (zh) * 2015-02-09 2015-05-13 李健 2-戊酰基-1,5-环己二烯-1-羧酸在制备治疗黄褐斑的药物中的应用
KR102107804B1 (ko) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 기억력 및 인지기능 개선용 펩타이드
KR102107806B1 (ko) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 기억력 및 인지기능 개선용 펩타이드 조성물
KR102107808B1 (ko) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 기억력 및 인지기능 개선용 펩타이드
CA3184258A1 (fr) * 2020-06-30 2022-01-06 Hyun Joon Kim Composition pour la prevention, l'amelioration ou le traitement des maladies provoquees par la nitration de la tyrosine dans une proteine contenant de la tyrosine comme principe acti

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030077902A (ko) * 2002-03-27 2003-10-04 대한민국(부경대학교 총장) 누에산물을 이용한 항치매환자식의 조성물
KR20040073425A (ko) * 2004-07-30 2004-08-19 주식회사 바이오그랜드 두뇌 또는 인지 기능 증진용 조성물
WO2006014033A1 (fr) * 2004-07-31 2006-02-09 Brainguard Co., Ltd. Peptide de soie ameliorant les effets neuroprotecteurs et neurofonctionnels et methode de preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030077902A (ko) * 2002-03-27 2003-10-04 대한민국(부경대학교 총장) 누에산물을 이용한 항치매환자식의 조성물
KR20040073425A (ko) * 2004-07-30 2004-08-19 주식회사 바이오그랜드 두뇌 또는 인지 기능 증진용 조성물
WO2006014033A1 (fr) * 2004-07-31 2006-02-09 Brainguard Co., Ltd. Peptide de soie ameliorant les effets neuroprotecteurs et neurofonctionnels et methode de preparation

Also Published As

Publication number Publication date
CN103209697A (zh) 2013-07-17
KR101048657B1 (ko) 2011-07-12
WO2012020991A2 (fr) 2012-02-16

Similar Documents

Publication Publication Date Title
WO2012020991A3 (fr) Composition pour prévenir et soulager une maladie du cerveau comprenant des acides aminés de la soie et la tyrosine comme ingrédients actifs
WO2012076466A3 (fr) Acides carboxyliques 1-benzylcycloalkyle substitués et leur utilisation
MY156777A (en) Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
IN2012DN02763A (fr)
WO2014014835A8 (fr) Formes cristallines d'un inhibiteur de la prolyl hydroxylase
NZ703341A (en) Compositions comprising apomorphine and organic acids and uses thereof
PH12015500106A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
WO2013184876A8 (fr) Inhibiteurs de bromo-domaine de benzo [c] isoxazoloazépines et applications associées
MY169980A (en) Bisaryl-linked aryltriazolones and their use
MY156434A (en) Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
WO2013134085A8 (fr) Inhibiteurs de la bêta-sécrétase
WO2012099449A3 (fr) Nouvelle utilisation d'un composé à base de flavone
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
WO2011107812A3 (fr) Composition pharmaceutique stabilisée
WO2014035860A8 (fr) Inhibiteurs de bêta-secrétase
ZA201300256B (en) Process for preparing crystalline 3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist
WO2013190455A3 (fr) Procédé pour la préparation de chlorhydrate de lurasidone
MX359554B (es) Microesferas cristalinas y proceso para fabricacion de las mismas.
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
EP2596787A4 (fr) Nouvelle utilisation de l'hespérétine
WO2010051138A3 (fr) Traitements cutanés contenant des dérivés d'idébénone substituée par un acide carboxylique et procédés pour les préparer et les utiliser
MD4375C1 (ro) Procedeu de sinteză enzimatică a (7S)-1-(3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il)-N-metil-metanaminei şi aplicarea în sinteza ivabradinei şi a sărurilor sale
UA108277C2 (ru) Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816607

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816607

Country of ref document: EP

Kind code of ref document: A2